| scholarly article | Q13442814 |
| P2093 | author name string | R Kuhn | |
| F Gasparini | |||
| C Thomsen | |||
| P J Flor | |||
| I Vranesic | |||
| N Stoehr | |||
| S Litschig | |||
| J P Pin | |||
| D Rueegg | |||
| L Prézeau | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 453-61 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding | |
| P478 | volume | 55 |
| Q37845809 | "Molecular switches" on mGluR allosteric ligands that modulate modes of pharmacology |
| Q42509881 | Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata. |
| Q42495060 | Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. |
| Q48115848 | Acute stress facilitates hippocampal CA1 metabotropic glutamate receptor-dependent long-term depression. |
| Q37272208 | Agonist-dependent signaling by group I metabotropic glutamate receptors is regulated by association with lipid domains |
| Q28362220 | Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives |
| Q24655595 | Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment |
| Q30448534 | Allosteric modulation of metabotropic glutamate receptors |
| Q37773480 | Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential |
| Q35952381 | Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery |
| Q35188110 | Allosteric modulation of the M₃ muscarinic receptor by amiodarone and N-ethylamiodarone: application of the four-ligand allosteric two-state model |
| Q37420479 | Allosteric modulators for mGlu receptors |
| Q28362867 | BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity |
| Q37948862 | Biased signalling and allosteric machines: new vistas and challenges for drug discovery |
| Q30414092 | Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behavior |
| Q37553926 | Cellular assays as portals to seven-transmembrane receptor-based drug discovery |
| Q64071827 | Computational Drug Design Applied to the Study of Metabotropic Glutamate Receptors |
| Q33415053 | Computing highly correlated positions using mutual information and graph theory for G protein-coupled receptors |
| Q46083239 | Control of neuronal excitability by Group I metabotropic glutamate receptors |
| Q24681622 | Cyclothiazide selectively inhibits mGluR1 receptors interacting with a common allosteric site for non-competitive antagonists |
| Q44584004 | Developmental shift from long-term depression to long-term potentiation in the rat medial vestibular nuclei: role of group I metabotropic glutamate receptors |
| Q44136807 | Different metabotropic glutamate receptors play opposite roles in synaptic plasticity of the rat medial vestibular nuclei |
| Q52653356 | Differential Pharmacology and Binding of mGlu2 Receptor Allosteric Modulators. |
| Q37021962 | Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation - possible role as a dependence receptor |
| Q34304685 | Dual signaling is differentially activated by different active states of the metabotropic glutamate receptor 1alpha |
| Q60920725 | Emerging Trends in Pain Modulation by Metabotropic Glutamate Receptors |
| Q43744854 | Endogenous activation of group-I metabotropic glutamate receptors is required for differentiation and survival of cerebellar Purkinje cells. |
| Q35014992 | Excitatory modulation in the cochlear nucleus through group I metabotropic glutamate receptor activation |
| Q37488533 | Extracellular calcium modulates actions of orthosteric and allosteric ligands on metabotropic glutamate receptor 1α. |
| Q93551696 | G Protein-Coupled Receptors |
| Q36692097 | G protein coupled receptor structure and activation |
| Q55278334 | G protein-coupled receptors: the evolution of structural insight. |
| Q93498472 | Glutamate, metabotropic |
| Q36249056 | Group 1 mGlu-family proteins promote neuroadaptation to ethanol and withdrawal-associated hippocampal damage |
| Q36961196 | Group I metabotropic glutamate receptors: a role in neurodevelopmental disorders? |
| Q43263515 | Group III metabotropic glutamate receptors as autoreceptors in the cerebellar cortex |
| Q35122994 | Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors. |
| Q30561814 | Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors |
| Q36183058 | Identification of acidic residues in the extracellular loops of the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+ and a positive allosteric modulator |
| Q43151071 | Interaction between Ephrins and mGlu5 metabotropic glutamate receptors in the induction of long-term synaptic depression in the hippocampus. |
| Q36054635 | Ionotropic and metabotropic glutamate receptor structure and pharmacology |
| Q40720745 | Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons. |
| Q43819965 | Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor. |
| Q37280041 | Metabotropic glutamate receptor ligands as potential therapeutics for addiction |
| Q41157725 | Metabotropic glutamate receptors: potential drug targets for psychiatric disorders |
| Q39196723 | Molecular Basis for Modulation of Metabotropic Glutamate Receptors and Their Drug Actions by Extracellular Ca2 |
| Q34468639 | Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation |
| Q39062474 | Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2. |
| Q26773431 | Neurobiological Insights from mGlu Receptor Allosteric Modulation |
| Q92057604 | Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors |
| Q45240186 | Number and density of AMPA receptors in single synapses in immature cerebellum. |
| Q34399823 | Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders |
| Q35287319 | Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism. |
| Q24555099 | Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site |
| Q37183072 | Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors |
| Q45163158 | Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. |
| Q38209092 | Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications |
| Q30455712 | Retracted: Inhibition of Spontaneous Recovery of Fear by mGluR5 after Prolonged Extinction Training |
| Q74241791 | Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death |
| Q37636314 | Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives |
| Q33890786 | Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery |
| Q43907009 | Signaling mechanisms of metabotropic glutamate receptor 5 subtype and its endogenous role in a locomotor network. |
| Q38649976 | Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators |
| Q28362372 | Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors |
| Q33828724 | Structure and ligand recognition of class C GPCRs |
| Q24338769 | Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator |
| Q36899701 | Structure-activity relationships of new 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor |
| Q30486707 | The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors |
| Q28366928 | The conductance underlying the parallel fibre slow EPSP in rat cerebellar Purkinje neurones studied with photolytic release of L-glutamate |
| Q34318688 | The heptahelical domain of GABA(B2) is activated directly by CGP7930, a positive allosteric modulator of the GABA(B) receptor |
| Q34074283 | The protective signaling of metabotropic glutamate receptor 1 Is mediated by sustained, beta-arrestin-1-dependent ERK phosphorylation. |
| Q43972769 | The requirement of presynaptic metabotropic glutamate receptors for the maintenance of locomotion. |
| Q36242605 | Vagal afferent stimulation activates astrocytes in the nucleus of the solitary tract via AMPA receptors: evidence of an atypical neural-glial interaction in the brainstem |
| Q38747119 | mGlu1 receptor as a drug target for treatment of substance use disorders: time to gather stones together? |
| Q37041639 | mGlu1 receptor mediates homeostatic control of intrinsic excitability through Ih in cerebellar Purkinje cells. |
| Q48224703 | mGluR1 enhances efferent inhibition of inner hair cells in the developing rat cochlea. |
| Q37642997 | mGluR1 within the nucleus accumbens regulates alcohol intake in mice under limited-access conditions |
| Q37693720 | mGluR4-positive allosteric modulation as potential treatment for Parkinson's disease. |
| Q44988763 | mGluR5: exploration of orthosteric and allosteric ligand binding pockets and their applications to drug discovery |
Search more.